Introduction
The presence of a single isoenzyme type of glucose-6-phosphate dehydrogenase (G-6-PD)' in erythroblasts, granulocytes, megakaryocytes, and probably lymphocytes in women with chronic myelogenous leukemia heterozygous for this enzyme and the presence of the Ph' chromosome in these cells provides evidence that all of these cell types may be derived from a neoplastic multipotential progenitor cell (1) (2) (3) . Rearrangement of immunoglobulin genes in the cells of lymphoid blast crisis suggests that the neoplastic clone also produces cells of the Blineage containing cytoplasmic immunoglobulin ,u chain (4) . The origin of T lymphocytes and B lymphocytes during the chronic phase of this disease remains uncertain.
To determine the lineage of mature T and B cells in chronic myelogenous leukemia in chronic phase, we used the culture assay for primary mixed colonies (CFU-GEMMT) (5) (6) (7) (8) (9) , and the technique of the clonal expansion of lymphoid elements (8) from such colonies to determine if lymphocytes 1. Abbreviations used in this paper: CFU-GEMMT, primary mixed hematopoietic colonies; EPO, erythropoietin; G-6-PD, glucose-6-phosphate dehydrogenase; PAP, peroxidase-anti-peroxidase; PHA, phytohemagglutinin; TCM, T cell conditioned medium.
grown from single colonies contained the Ph' chromosome. We have recloned secondary colonies of lymphocytes derived from CFU-GEMMT colonies containing the Ph' chromosome, we have identified the lymphocyte lineage of these cells using monoclonal lymphocyte markers (10, 11) , and we have examined these for the Ph' chromosome. The study demonstrates that such secondary colonies, characterized at T lymphocytes by such markers, contain the Ph' chromosome and thus seem to be derived from the neoplastic clone.
Methods
Patient. Bone marrow was obtained from a 34-yr-old male with newly diagnosed chronic myelogenous leukemia in chronic phase before any treatment. The Philadelphia chromosome (Ph') was present in all examined metaphases. (8) .
Recloning of hematopoietic colonies. Individually aspirated CFU-GEMMT were divided into two parts. One portion was examined for the presence of T cells or B cells by using the peroxidase-antiperoxidase (PAP) slide technique. The second portion of each individual clone was replated as single cell suspensions in microtiter wells (Linbro Chemical Co., Hamden, CT). To stimulate lymphocyte proliferation, secondary plates contained 2.5% PHA-TCM and 0.5% PHA; no EPO was added. After 12 d of culture, the plates (Linbro Chemical Co.) were scored for secondary hematopoietic colonies. They were counted and individual colonies were aspirated by micropipette as described for primary colonies (8) . The secondary colonies were again dissected into two portions. One portion of each individual colony was examined for cells expressing T cell antigens using Leu-5 and OKT3. The second portion was subjected to cytogenetic analysis (3).
T cell and B cell markers on primary mixed hematopoietic colonies. Individual colonies were aspirated from the cultures by micropipette and were washed in Eppendorf micro test tubes. The pellets were resuspended after centrifugation (5 min, 300 g). The aliquots were either transferred onto poly-L-Lysine coated glass slides for staining of surface antigens, i.e., anti-Leu-5 and BI, by the PAP method using a glass slide technique described earlier (14, 15), or they were subcloned.
T cell markers in secondary hematopoietic colonies. Individual secondary colonies were aspirated and washed as described. The pellet was resuspended and one portion was transferred onto the coated glass slides for surface antigen staining by the PAP method using anti-Leu-5 or OKT3. The second portions were subjected to cytogenetic analysis (3, 16) .
Cytogenetic analysis of hemopoietic colonies. Mixed hemopoietic colonies, erythroid bursts, granulocytic colonies, and aliquots derived from individual secondary colonies were subjected to chromosome analysis (3). 14 mixed colonies, 25 erythroid bursts, 25 granulocytic colonies, and 39 secondary T cell colonies were examined. Examination of the 21 mixed colonies that grew in the absence of EPO revealed three colonies with B1 positive cells, a proportion not different from those found in the presence of EPO.
Analysis ofsecondary T cell colonies derivedfrom multilineage colonies. A number of primary multilineage colonies formed secondary colonies upon replating in the presence of 2.5% PHA-TCM and 0.5% PHA. After 12 d of culture, individual secondary colonies were aspirated, washed, and split into two portions. The smaller portion of each individual secondary colony was analyzed for Leu-5 or OKT3 staining. All examined cells within each individual colony were either Leu-5 or OKT3 positive.
Erythroid bursts and granulocytic colonies did not form secondary colonies upon replating and did not react with OKT3 or Leu-5 antibodies.
Cytogenetic analysis of secondary T cell colonfes derived from multilineage primary colonies. Cells derived from 39 individual secondary T cell colonies confirmed by the reaction with Leu-5 were subjected to cytogenetic analysis. The examination of 39 individual colonies revealed metaphases in 13 of them. In 10 preparations, one metaphase was observed, and in 3 preparations, two metaphases were identified. In addition, eight secondary colonies were examined by OKT3. All cells were OKT3 positive. All metaphases obtained from the secondary colonies were Ph' positive, as were the metaphases obtained from individually examined mixed hematopoietic colonies, erythroid bursts, and granulocytic colonies.
Discussion
The development of an in vitro assay for CFU-GEMMT has provided a means of examining the progeny of single multipotent hemopoietic stem cells in human bone marrow when this is plated at a low density of cells. We have previously reported the presence of "pre-B" cells in such colonies from normal subjects ( 13) , and of B cells from both normal subjects and patients with lymphocytic lymphoma (17) . Different phenotypes of T lymphocytes have also been observed in such colonies, including T cells reacting with the monoclonal antibodies OKT3 and OKT4 (7, 8) , and cytotoxic T cells with OKT8 phenotype from patients with Hodgkins Disease (9) .
We report the presence of subclones of cells with the T lymphocyte phenotype from single colonies grown from a patient in the chronic phase of chronic myelocytic leukemia. All metaphases examined of these subclones contained the Ph' chromosome, as did metaphases of erythroid and myeloid cells. Cells with the B lymphocyte phenotype were also subcloned from mixed colonies from this patient but cytogenetic analysis of these is not available. This demonstrates that as in normal subjects, single stem cells from this patient could produce both lymphoid and myeloid progeny, and that the Ph' chromosome was present in both hemopoietic and T lymphocyte progeny.
Evidence using G-6-PD subtypes and cytogenetic analysis has been published that in some patients with chronic myelocytic leukemia, lymphocytes may be derived from the same cell as the hemopoietic elements. The study provides direct proof of this, and suggests that the Ph' chromosome probably is present in a very early transformed stem cell in this disease.
